Luye Pharma Group Ltd. (HKG:2186)
Hong Kong
· Delayed Price · Currency is HKD 3.260
-0.150 (-4.40%)
Jun 19, 2025, 4:08 PM HKT
Revenue by Product
Fiscal year is January - December.
Year Ending | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | NaN - NaN |
|---|---|---|---|---|---|---|
| Oncology Drugs | 2.35B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Oncology Drugs Growth | -12.54% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Central Nervous System Drugs | 1.87B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Central Nervous System Drugs Growth | 21.74% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Cardiovascular System Drugs | 1.86B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Cardiovascular System Drugs Growth | 4.41% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Alimentary Tract and Metabolism Drugs | 497.71M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Alimentary Tract and Metabolism Drugs Growth | -32.32% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other | 208.07M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Growth | -3.29% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Revenue by Geography
Fiscal year is January - December.
Year Ending | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | NaN - NaN |
|---|---|---|---|---|---|---|
| China | 5.56B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| China Growth | -5.01% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| European Union | 497.22M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| European Union Growth | 38.30% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Asia (Other than China) | 493.63M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Asia (Other than China) Growth | 23.95% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Countries | 239.53M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
| Other Countries Growth | -31.07% |
Log In |
Log In |
Log In |
Log In | Upgrade
|